CPRX
Catalyst Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$23.23
-0.16 ▼ -0.68%
🌙 3월 13일 7:45 PM ET (한국 3/14 08:45)
$23.71
+0.48 ▲ +2.07%
| Index | RUT | P/E | 13.79 | EPS (ttm) | 1.68 | Insider Own | 10.16% | Shs Outstand | 0.12B | Perf Week | -4.17% |
| Market Cap | 2.84B | Forward P/E | 10.78 | EPS next Y | 16.56% | Insider Trans | -0.3% | Shs Float | 0.11B | Perf Month | -2.93% |
| Enterprise Value | 2.13B | PEG | 1.08 | EPS next Q | 0.45 | Inst Own | 82.07% | Short Float | 8.46% | Perf Quarter | 1.89% |
| Income | 0.21B | P/S | 4.82 | EPS this Y | 10% | Inst Trans | 1.16% | Short Ratio | 7.39 | Perf Half Y | 14.72% |
| Sales | 0.59B | P/B | 2.98 | EPS next 5Y | 9.98% | ROA | 21.86% | Short Interest | 9.29M | Perf YTD | -0.47% |
| Book/sh | 7.79 | P/C | 4 | EPS past 3/5Y | 31.19% 19% | ROE | 25.49% | 52W High | -12.6% ($26.58) | Perf Year | 11.31% |
| Cash/sh | 5.81 | P/FCF | 13.6 | Sales past 3/5Y | 40.1% 37.68% | ROIC | 22.4% | 52W Low | 21.94% ($19.05) | Perf 3Y | 58.78% |
| Dividend Est. | - | EV/EBITDA | 7.2 | EPS Y/Y TTM | 27.02% | Gross Margin | 78.82% | Volatility(W/M) | 3.19% 4% | Perf 5Y | 497.17% |
| Dividend TTM | - | EV/Sales | 3.62 | Sales Y/Y TTM | 19.78% | Oper. Margin | 43.77% | ATR (14) | 0.93 | Perf 10Y | 1804.1% |
| Dividend Ex-Date | - | Quick Ratio | 5.82 | EPS Q/Q | -6.64% | Profit Margin | 36.39% | RSI (14) | 41.85 | Recom | 1.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.08 | Sales Q/Q | 7.61% | SMA20 | -4.15% ($24.24) | Beta | 0.7 | Target Price | $34 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | -2.85% ($23.91) | Rel Volume | 0.82 | Prev Close | $23.39 |
| Employees | 182 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 19.19% 6.84% | SMA200 | 4.1% ($22.32) | Avg Volume(3M) | 1.26M | Price | $23.23 |
| IPO | 2006/11/8 | Option/Short | Yes/Yes | Trades | 10113 | Volume | 1,024,009 | Change | -0.68% |
뉴스 로딩 중...